99.4%
Images are representative. Products are lyophilised research peptides in sterile vials. COA shown above when available for the current batch.
Cagrilintide
Long-acting lipidated amylin analog for weight management and metabolic research.
In Stock
Batch-specific COA available on request — ask us on WhatsApp.
HPLC Purity — 99.4%
Select Variant
Qty
1
Total₹4,999
48h
Dispatch
Cagrilintide (AM833) is a long-acting lipidated amylin analog acting as a dual amylin and calcitonin receptor agonist, with a half-life of approximately 7.5 days that supports once-weekly dosing. Phase 3 research has demonstrated significant weight reduction as monotherapy and superior efficacy in combination with semaglutide (CagriSema), reaching up to 22.7% weight loss in trial participants. Each vial is lyophilised under nitrogen, HPLC-verified at ≥99% purity, and ships with a full Certificate of Analysis.
2.5
mg/ml
0.1
ml/dose
10
units (U-100)
20
doses/vial
For research calculation only. Not dosing guidance. U-100 = 100 units per ml.
Store lyophilised vials refrigerated (2–8°C), protected from light. Once reconstituted, keep refrigerated and use within the period appropriate to the compound. Shipped in insulated, temperature-controlled packaging.
This product is strictly for laboratory and analytical purposes. Not for human or veterinary use. By ordering, you confirm you are a qualified researcher operating in compliance with applicable regulations.